Long-term outcome of myeloablative allogeneic stem cell transplantation for multiple myeloma.

@article{Kuruvilla2007LongtermOO,
  title={Long-term outcome of myeloablative allogeneic stem cell transplantation for multiple myeloma.},
  author={John Kuruvilla and John D. Shepherd and Heather J. Sutherland and Thomas J. Nevill and Janet Y Nitta and Aulan Le and Donna L. Forrest and Donna Hogge and Julye C Lavoie and Stephen H Nantel and Cynthia L Toze and Clayton Smith and Micheal J Barnett and Kevin W. Song},
  journal={Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation},
  year={2007},
  volume={13 8},
  pages={925-31}
}
Allogeneic stem cell transplantation (alloSCT) has been used in the hopes of harnessing the curative potential of the graft-versus-myeloma effect. This study examines the long-term outcomes of a large cohort of patients with myeloma who were treated with myeloablative alloSCT at a single center. Comparisons are made with those who were treated with autologous stem cell transplantation (ASCT). Between January 1989 and February 2002, 158 patients age<or=55 years underwent SCT for myeloma. Seventy… CONTINUE READING
11 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 11 extracted citations

Similar Papers

Loading similar papers…